Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics

Main Article Content

Mark Lebwohl
Lawrence Green
Miriam Bettencourt
Scott Fretzin
Abby Jacobson

Keywords

psoriasis, brodalumab

Abstract

Abstract not available.

References

1. Foster et al. J Manag Care Spec Pharm. 2016;22:396-405.

2. Siliq [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America, LLC; 2017.

3. Lebwohl et al. N Engl J Med. 2015;373:1318-1328.